HEMECDx, a high-throughput gene assay developed by MEDx Translational Medicine (Suzhou) Co., Ltd, is used to detect abnormal mutations of key genes in hematological malignancies like leukemia and lymphoma. MEDx provides physicians and patients with several products by which the comprehensive analysis of the genome (DNA) and transcriptome (RNA) can be conducted to help clinicians make right diagnosis and prognosis stratification, treatment, and recurrence monitoring.
If you have any of the following needs, feel free to contact us or email us at inquiry@MEDxTMC.net . We will reply within 24 hours.
1. Customized or bulk orders of IVD/CDx products.
2. Get a quote for IVD/CDx products
3. Become our distributor
4. Get customized pharmaceutical service solutions
5.Learn more about our technology and R&D